Supplemental material
Emerging Microbes & Infections
Volume 8, 2019 - Issue 1
Original Articles
Limited evolution of the yellow fever virus 17d in a mouse infection model
Dieudonné Buh Kuma KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium;b Aligos Belgium, Leuven, Belgium
https://orcid.org/0000-0001-8251-8230View further author information
https://orcid.org/0000-0001-8251-8230View further author information, Niraj Mishraa KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgiumhttps://orcid.org/0000-0002-8679-8847View further author information
https://orcid.org/0000-0002-8679-8847View further author information, Bram Vranckenc KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory for Clinical and Epidemiological Virology, Leuven, Belgiumhttps://orcid.org/0000-0001-6547-5283View further author information
https://orcid.org/0000-0001-6547-5283View further author information, Hendrik Jan Thibauta KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgiumhttps://orcid.org/0000-0001-5785-8276View further author information
https://orcid.org/0000-0001-5785-8276View further author information, Annelies Wilder-Smithd Department of Disease Control, London School of Hygiene and Tropical Medicine, London, United Kingdom;e Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germanyhttps://orcid.org/0000-0003-0362-5375View further author information
https://orcid.org/0000-0003-0362-5375View further author information, Philippe Lemeyc KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory for Clinical and Epidemiological Virology, Leuven, Belgiumhttps://orcid.org/0000-0003-2826-5353View further author information
https://orcid.org/0000-0003-2826-5353View further author information, Johan Neytsa KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, BelgiumCorrespondence[email protected]
https://orcid.org/0000-0002-0033-7514View further author information
https://orcid.org/0000-0002-0033-7514View further author information & Kai Dallmeiera KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, BelgiumCorrespondence[email protected]
https://orcid.org/0000-0002-8117-9166View further author information
https://orcid.org/0000-0002-8117-9166View further author information show allRelated Research Data
The phylogeny of yellow fever virus 17D vaccines.
Source:
Elsevier BV
A yellow fever-Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice.
Source:
Nature Research (part of Springer Nature)
A double blind, randomized clinical trial of immunogenicity and safety on a dose-response study
Source:
Informa UK Limited
Fidelity of RNA polymerase II transcription controlled by elongation factor TFIIS
Source:
Proceedings of the National Academy of Sciences
Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice.
Source:
Public Library of Science (PLoS)
Epidemic arboviral diseases: priorities for research and public health
Source:
Elsevier BV
Molecular characterization of the 17D-204 yellow fever vaccine.
Source:
Elsevier BV
Conditionally Amplifiable BACs: Switching From Single-Copy to High-Copy Vectors and Genomic Clones
Source:
Cold Spring Harbor Laboratory
Yellow Fever: Epidemiology and Prevention
Source:
Oxford University Press (OUP)
Yellow fever vaccination: estimating coverage.
Source:
Elsevier BV
Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology
Source:
Springer Science and Business Media LLC
Antigenic cartography of H1N1 influenza viruses using sequence-based antigenic distance calculation.
Source:
Springer Science and Business Media LLC
Adverse event reports following yellow fever vaccination, 2007-13.
Source:
Oxford University Press (OUP)
Simple and inexpensive three-step rapid amplification of cDNA 5' ends using 5' phosphorylated primers.
Source:
Elsevier Inc.
Dynamic viral dissemination in mice infected with yellow fever virus strain 17D
Source:
American Society for Microbiology
Dynamics of Hepatitis B Virus Quasispecies in Association with Nucleos(t)ide Analogue Treatment Determined by Ultra-Deep Sequencing
Source:
Public Library of Science (PLoS)
A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection
Source:
Public Library of Science (PLoS)
Error detecting and error correcting codes
Source:
Monterey, California: Naval Postgraduate School
Yellow fever 17D vaccine virus isolated from healthy vaccinees accumulates very few mutations.
Source:
Elsevier BV
Collaborative study to assess the suitability of a candidate International Standard for yellow fever vaccine.
Source:
Elsevier BV
A Derivate of the Antibiotic Doxorubicin Is a Selective Inhibitor of Dengue and Yellow Fever Virus Replication In Vitro
Source:
American Society for Microbiology
Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population
Source:
Springer Science and Business Media LLC
Fractional-Dose Yellow Fever Vaccination - Advancing the Evidence Base.
Source:
Massachusetts Medical Society
A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain.
Source:
Elsevier BV
Review of the risks and benefits of yellow fever vaccination including some new analyses.
Source:
Informa UK Limited
Bottleneck-mediated quasispecies restriction during spread of an RNA virus from inoculation site to brain.
Source:
Proceedings of the National Academy of Sciences
Yellow fever vaccine — how does it work and why do rare cases of serious adverse events take place?
Source:
Elsevier BV
Linking provided by
